Scott M McGinnis
Overview
Explore the profile of Scott M McGinnis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
461
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Case Study 9: A 64-Year-Old Man With Rapidly Progressive Cognitive Impairment and Behavioral Changes
Kamal S, Kryatova M, Gale S, Daffner K, Silbersweig D, McGinnis S, et al.
J Neuropsychiatry Clin Neurosci
. 2025 Feb;
:appineuropsych20240198.
PMID: 39962977
No abstract available.
2.
Gibson L, Krause K, Gale S, Schildkrout B, Miller M, Feany M, et al.
J Neuropsychiatry Clin Neurosci
. 2025 Jan;
:appineuropsych20240125.
PMID: 39885722
No abstract available.
3.
Katsumi Y, Eckbo R, Chapleau M, Wong B, McGinnis S, Touroutoglou A, et al.
Alzheimers Res Ther
. 2024 Dec;
16(1):262.
PMID: 39696378
Background: Posterior Cortical Atrophy (PCA) is a clinical syndrome characterized by progressive visuospatial and visuoperceptual impairment. As the neurodegenerative disease progresses, patients lose independent functioning due to the worsening of...
4.
Katsumi Y, Eckbo R, Chapleau M, Wong B, McGinnis S, Touroutoglou A, et al.
medRxiv
. 2024 Nov;
PMID: 39484250
Background And Objectives: Posterior Cortical Atrophy (PCA) is a clinical syndrome characterized by progressive visuospatial and visuoperceptual impairment. As the neurodegenerative disease progresses, patients lose independent functioning due to the...
5.
Katsumi Y, Howe I, Eckbo R, Wong B, Quimby M, Hochberg D, et al.
Brain
. 2024 Oct;
PMID: 39412999
Identifying individuals with early-stage Alzheimer's disease (AD) at greater risk of steeper clinical decline would enable better-informed medical, support, and life planning decisions. Despite accumulating evidence on the clinical prognostic...
6.
Gettens Bourgea K, Erkkinen M, Gale S, McGinnis S, Daffner K, Silbersweig D, et al.
J Neuropsychiatry Clin Neurosci
. 2024 Jun;
36(3):220-227.
PMID: 38835225
No abstract available.
7.
Katsumi Y, Howe I, Eckbo R, Wong B, Quimby M, Hochberg D, et al.
medRxiv
. 2024 May;
PMID: 38699357
Identifying individuals with early stage Alzheimer's disease (AD) at greater risk of steeper clinical decline would allow professionals and loved ones to make better-informed medical, support, and life planning decisions....
8.
Ramirez-Salazar S, MacRae C, Feany M, Miller M, Yang H, Meadows M, et al.
J Neuropsychiatry Clin Neurosci
. 2023 Oct;
35(4):325-332.
PMID: 37840261
No abstract available.
9.
McGinnis S, McCann R, Patel V, Doughty C, Miller M, Gale S, et al.
J Neuropsychiatry Clin Neurosci
. 2023 Jul;
35(3):210-217.
PMID: 37448308
No abstract available.
10.
Sarkis R, Gale S, Yang H, Lam A, Singhal T, Cicero S, et al.
Am J Alzheimers Dis Other Demen
. 2023 Mar;
38:15333175231160005.
PMID: 36892007
In older adults with cognitive decline and epilepsy, diagnosing the etiology of cognitive decline is challenging. We identified 6 subjects enrolled in the Imaging Dementia-Evidence of Amyloid Imaging Scanning (IDEAS)...